ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher ...

NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law ...

Shares of Regeneron Pharmaceuticals Inc. slid 3.61% to $665.46 Tuesday, on what proved to be an all-around favorable trading ...

Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.

Registration is open for the 44th annual County Science and Engineering Fair. The fair is for middle and high school students ...

Investing in stocks that aren't performing well can be a good move, but only if there are good reasons to think they will ...

In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.

Eli Hanechak claims to have a patent pending on an enzyme mutation that could accelerate the breakdown of plastic waste.

The sessions may be accessed from the "Investors & Media" page of Regeneron's website at https://investor.regeneron.com/events-and-presentations. Replays and transcripts of the webcasts will be ...

The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...